The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 677.00
Bid: 601.00
Ask: 900.00
Change: 0.00 (0.00%)
Spread: 299.00 (49.75%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 677.00
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FULL PENSION SCHEME BUY-IN WITH LEGAL & GENERAL

19 Sep 2019 07:00

RNS Number : 8661M
Tate & Lyle PLC
19 September 2019
 

 

 

TATE & LYLE ENTERS INTO FULL DEFINED BENEFIT PENSION SCHEMEBUY-IN WITH LEGAL & GENERAL

 

Agreement will deliver security for UK Scheme members while removing future riskfor Tate & Lyle and saving £20 million of annual contributions

 

19 September, 2019, London, UK: Tate & Lyle PLC ("the Company") and the Trustee of the Tate & Lyle Group Pension Scheme ("the Scheme"), the Group's UK pension scheme, today announce an agreement for a £930 million bulk annuity insurance 'buy-in' with Legal & General Assurance Society Limited ("Legal & General"). The agreement provides certainty and security for the Scheme's affected members.

 

The buy-in secures an insurance asset from Legal & General that fully1 matches the remaining pension liabilities of the Scheme, with the result that the Company no longer bears any investment, longevity, interest rate or inflation risk in respect of the Scheme. Under the transaction, the Company will not contribute any incremental funding into the Scheme1.

 

The agreement is not anticipated to impact profit before tax for the year ending 31 March 2020 but will eliminate non-cash net finance income on the UK scheme accounting surplus2 from the 2021 financial year. De-recognition of the accounting surplus will result in a decrease in Group net equity by around £180 million.

 

Imran Nawaz, Chief Financial Officer of Tate & Lyle PLC, said:

 

"This transaction represents a good outcome for our UK scheme members, the Company and our shareholders. We have supported the Scheme over many decades and made significant cash contributions to remedy a deficit that has existed between the Scheme's assets and liabilities. That funding, combined with excellent stewardship by the Scheme's trustees, has meant that the Scheme can now be de-risked for the benefit of members and the Company.

 

"Importantly, cash contributions into the Scheme will cease, saving around £20 million of cash annually from the 2021 financial year1, allowing the Company to focus our future investments on delivering profitable growth."

 

Michael Chatterton, Chairman of Trustees of the Scheme, said:

 

"This is great news for Scheme members. After many years of funding from Tate & Lyle and careful management, working together in close partnership with the Company, we have now secured our members' benefits through Legal & General. As a result, our members can continue to look forward to enjoying retirement knowing that their pensions are secure."

 

 

1 Subject to final price adjustment for bulk annuity pricing.

2 In the year ended 31 March 2019 net finance income on the UK scheme was £5 million.

 

END

 

Contacts:

 

Anna Taylor (media)

Corporate PR Manager

Tel: +44 (0)207 257 2209 or mobile: +44 (0)7766 361 515

mediaenquiries@tateandlyle.com

 

Christopher Marsh (investors)

VP Investor Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688

 

 

About Tate & Lyle: 

 

Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.

 

Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.

 

Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.

 

Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants). It also sells co-products from the corn milling process as animal nutrition.

 

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2019, Tate & Lyle sales totalled £2.8 billion.

 

For more information, please visit http://www.tateandlyle.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKFDKABKDDCD
Date   Source Headline
17th Jul 20197:02 amRNSChange to Executive Committee
1st Jul 201912:40 pmRNSBlock listing Interim Review
1st Jul 201912:38 pmRNSTotal Voting Rights
1st Jul 201912:00 pmRNSDirector/PDMR Shareholding
10th Jun 201911:30 amRNSAnnual Financial Report
5th Jun 20199:52 amRNSHolding(s) in Company
5th Jun 20199:34 amRNSDirector/PDMR Shareholding
3rd Jun 201910:42 amRNSTotal Voting Rights
29th May 20194:00 pmRNSDirector/PDMR Shareholding
28th May 20194:12 pmRNSDirector/PDMR Shareholding
23rd May 20197:00 amRNSFinal Results
9th May 201911:00 amRNSDirectorate Change
1st May 201910:00 amRNSTotal Voting Rights
1st Apr 20194:17 pmBUSTotal Voting Rights
1st Apr 20193:45 pmBUSHolding(s) in Company
1st Mar 201911:21 amBUSTotal Voting Rights
27th Feb 20191:00 pmBUSHolding(s) in Company
7th Feb 20197:00 amBUSTrading Statement
1st Feb 201911:40 amBUSTotal Voting Rights
3rd Jan 20192:00 pmBUSDirector/PDMR Shareholding
2nd Jan 20193:53 pmBUSBlock listing Interim Review
6th Dec 201811:32 amBUSDirector/PDMR Shareholding
5th Dec 20182:22 pmBUSDirector/PDMR Shareholding
3rd Dec 20183:34 pmBUSTotal Voting Rights
19th Nov 20187:00 amBUSDirectorate change
8th Nov 20187:00 amBUSHalf-year Report
1st Nov 201812:20 pmBUSTotal Voting Rights
5th Oct 20182:05 pmBUSDirector/PDMR Shareholding
1st Oct 20182:25 pmBUSTotal Voting Rights
21st Sep 201811:43 amBUSDirector/PDMR Shareholding
10th Jul 201811:21 amBUSDirector/PDMR Shareholding
10th Jul 201810:50 amBUSHolding(s) in Company
2nd Jul 20183:42 pmBUSTotal Voting Rights
2nd Jul 20183:11 pmBUSBlock listing Interim Review
28th Jun 20185:37 pmBUSDirector/PDMR Shareholding
21st Jun 201812:34 pmBUSAnnual Financial Report
14th Jun 20185:34 pmBUSDirector/PDMR Shareholding
6th Jun 20186:21 pmBUSDirector/PDMR Shareholding
1st Jun 201812:44 pmBUSTotal Voting Rights
29th May 20185:54 pmBUSDirector/PDMR Shareholding
24th May 20187:00 amBUSFinal Results
1st May 20181:00 pmBUSTotal Voting Rights
18th Apr 201812:27 pmBUSDirector/PDMR Shareholding
17th Apr 20187:00 amBUSImran Nawaz Appointed Chief Financial Officer of Tate & Lyle PLC
13th Apr 20181:48 pmBUSDirector Declaration
5th Apr 20184:31 pmBUSDirector/PDMR Shareholding
4th Apr 20184:47 pmBUSDirector/PDMR Shareholding
3rd Apr 201812:27 pmBUSTotal Voting Rights
2nd Mar 201812:04 pmBUSDirector/PDMR Shareholding
15th Feb 20183:44 pmBUSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.